Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted
2023-05-06 21:00
Empowering Innovation to the Global Market with Acro Certify
2023-05-06 10:18
CARsgen's CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer
2023-05-05 20:50
ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments
2023-05-05 18:00
Arbele celebrates its 7th anniversary as a clinical-stage immunotherapy biotech and the opening of TibTech, its cancer diagnostics subsidiary
2023-05-05 15:00
Formosa Pharmaceuticals and AimMax Therapeutics Announce the NDA Submission to the US FDA for APP13007 for the Treatment of Post-Operative Inflammation and Pain following Ocular Surgery
2023-05-05 08:00
Recall Notice - SD Biosensor, Inc. requests discontinuation of use and disposal of specific Pilot™ COVID-19 At-Home Tests in the United States due to microbial contamination in the liquid buffer solution
2023-05-05 04:00
ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tumor
2023-05-05 01:00
DetectedX's Radiology Online Learning Centre Passes 4,500 Users
2023-05-04 23:25
Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®
2023-05-04 14:00
Full-Life Technologies Announces Land Purchase in Belgium to Establish GMP Manufacturing Facility for Radiopharmaceutical Drug Production
2023-05-04 10:00
EDAN Announces Integration with PointClickCare for Better Senior Primary Care
2023-05-03 21:56
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting
2023-05-03 12:00
China Jo-Jo Drugstores Receives Hangzhou Municipal People's Government Quality Management Excellence Award
2023-05-02 20:30
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Completes Purchase of Land Use Right of Nearly 50,000 Square Meters in Hainan Free Trade Port Boao Hope City for the Construction of Integrated Medical Industrial Park
2023-05-01 20:30
I-MAB Filed 2022 Annual Report on Form 20-F
2023-05-01 20:00
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products
2023-04-29 23:20
ISS Collaboration - Singleron Biotechnologies GmbH joined the pursuit of "Reaching for the Stars"
2023-04-28 20:56
HanAll Biopharma Reports First Quarter Results and Provides Business Update
2023-04-28 19:00
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
2023-04-28 17:00
1
81
82
83
84
85
431